Board Meeting Scheduled to Approve Q1 Financial Results
Suven Life Sciences Limited · SUVEN · NSE ·
• A meeting of the Board of Directors is scheduled for August 06, 2026. • The purpose of the meeting is to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.